Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 1
2006 4
2007 4
2009 4
2010 7
2011 5
2012 3
2013 2
2014 4
2015 4
2016 6
2017 4
2018 5
2019 4
2020 8
2021 15
2022 5
2023 5
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells.
Velasco-Hernandez T, Trincado JL, Vinyoles M, Closa A, Martínez-Moreno A, Gutiérrez-Agüera F, Molina O, Rodríguez-Cortez VC, Ximeno-Parpal P, Fernández-Fuentes N, Petazzi P, Beneyto-Calabuig S, Velten L, Romecin P, Casquero R, Abollo-Jiménez F, de la Guardia RD, Lorden P, Bataller A, Lapillonne H, Stam RW, Vives S, Torrebadell M, Fuster JL, Bueno C, Sarry JE, Eyras E, Heyn H, Menéndez P. Velasco-Hernandez T, et al. Among authors: fernandez fuentes n. Hemasphere. 2024 Feb 26;8(2):e45. doi: 10.1002/hem3.45. eCollection 2024 Feb. Hemasphere. 2024. PMID: 38435427 Free PMC article.
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.
Lopez-Millan B, Rubio-Gayarre A, Vinyoles M, Trincado JL, Fraga MF, Fernandez-Fuentes N, Guerrero-Murillo M, Martinez A, Velasco-Hernandez T, Falgàs A, Panisello C, Valcarcel G, Sardina JL, López-Martí P, Javierre BM, Del Valle-Pérez B, García de Herreros A, Locatelli F, Pieters R, Bardini M, Cazzaniga G, Rodríguez-Manzaneque JC, Hanewald T, Marschalek R, Milne TA, Stam RW, Tejedor JR, Menendez P, Bueno C. Lopez-Millan B, et al. Among authors: fernandez fuentes n. Blood. 2024 Nov 7;144(19):2002-2017. doi: 10.1182/blood.2023022050. Blood. 2024. PMID: 39093982 Free article.
LILRB1-directed CAR-T cells for the treatment of hematological malignancies.
Marhelava K, Fidyt K, Pepek M, Krawczyk M, Forcados C, Malinowska A, Swiderska B, Fernandez-Fuentes N, Czerwik N, Baranowska I, Krzywdzinska A, Sedek L, Slota L, Perkowski B, Villatoro A, Leray T, Lech-Maranda E, Menendez P, Inderberg EM, Wälchli S, Winiarska M, Firczuk M. Marhelava K, et al. Among authors: fernandez fuentes n. Leukemia. 2025 Jun;39(6):1395-1411. doi: 10.1038/s41375-025-02580-z. Epub 2025 Apr 5. Leukemia. 2025. PMID: 40186066 Free PMC article.
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.
Molina O, Ortega-Sabater C, Thampi N, Fernández-Fuentes N, Guerrero-Murillo M, Martínez-Moreno A, Vinyoles M, Velasco-Hernández T, Bueno C, Trincado JL, Granada I, Campos D, Giménez C, Boer JM, den Boer ML, Calvo GF, Camós M, Fuster JL, Velasco P, Ballerini P, Locatelli F, Mullighan CG, Spierings DCJ, Foijer F, Pérez-García VM, Menéndez P. Molina O, et al. Among authors: fernandez fuentes n. EMBO Mol Med. 2024 Jan;16(1):64-92. doi: 10.1038/s44321-023-00006-w. Epub 2023 Dec 15. EMBO Mol Med. 2024. PMID: 38177531 Free PMC article.
Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.
Esquinas E, Moreno-Sanz A, Sandá V, Stodulski-Ciesla D, Borregón J, Peña-Blanque V, Fernández-Calles J, Fernandez-Fuentes N, Serrano-Lopez J, Juan M, Engel P, Llamas-Sillero P, Solán-Blanco L, Martin-Antonio B. Esquinas E, et al. Among authors: fernandez fuentes n. J Immunother Cancer. 2024 Dec 18;12(12):e009485. doi: 10.1136/jitc-2024-009485. J Immunother Cancer. 2024. PMID: 39694704 Free PMC article.
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.
Falgàs A, Lázaro-Gorines R, Zanetti SR, Rubio-Pérez L, Martínez-Moreno A, Vinyoles M, Guerrero-Murillo M, Fernández-Fuentes N, Roca-Ho H, Tirado N, Panisello C, Velasco-Hernandez T, Mayado A, Pérez-Pons A, Genescà E, Ribera JM, Ribera J, Camos M, Ramírez-Orellana M, Anguita E, Ballerini P, Fuster JL, Juan M, González-Navarro EA, Locatelli F, Stam RW, Querol S, Velasco P, Ortiz-Maldonado V, Martínez-Cibrián N, Delgado J, Orfao A, Álvarez-Vallina L, Bueno C, Menéndez P. Falgàs A, et al. Among authors: fernandez fuentes n. Blood. 2025 May 29;145(22):2599-2613. doi: 10.1182/blood.2024025440. Blood. 2025. PMID: 40090006
Theoretical 3D Modeling of NLRP3 Inflammasome Complex.
Bota PM, Oliva B, Fernandez-Fuentes N. Bota PM, et al. Among authors: fernandez fuentes n. Methods Mol Biol. 2023;2696:269-280. doi: 10.1007/978-1-0716-3350-2_18. Methods Mol Biol. 2023. PMID: 37578729
SBILib: a handle for protein modeling and engineering.
Gohl P, Bonet J, Fornes O, Planas-Iglesias J, Fernandez-Fuentes N, Oliva B. Gohl P, et al. Among authors: fernandez fuentes n. Bioinformatics. 2023 Oct 3;39(10):btad613. doi: 10.1093/bioinformatics/btad613. Bioinformatics. 2023. PMID: 37796837 Free PMC article.
93 results